ScholarIQanswers from OpenAlex & ORCID
Robert Z. Orlowski
ResearcherPublications, citations & collaboration network
Robert Z. Orlowski is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Robert Z. Orlowski have?
ScholarIQindexed works
Robert Z. Orlowski has 1,166 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Robert Z. Orlowski have?
ScholarIQcitation count
Robert Z. Orlowski has 54,329 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Robert Z. Orlowski?
ScholarIQh-index
Robert Z. Orlowski has an h-index of 102 in OpenAlex.
What is the i10-index of Robert Z. Orlowski?
ScholarIQi10-index
Robert Z. Orlowski has an i10-index of 397 in OpenAlex.
What is the ORCID of Robert Z. Orlowski?
ScholarIQorcid
The ORCID for Robert Z. Orlowski is on the source record.
What is the OpenAlex record for Robert Z. Orlowski?
ScholarIQopenalex
The OpenAlex for Robert Z. Orlowski is on the source record.
What are the most-cited papers on Robert Z. Orlowski?
ScholarIQmost cited works
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar, Bruno Paiva, Kenneth C. Anderson, Brian G.M. Durie, Ola Landgren, Philippe Moreau, Nikhil C. Munshi, Sagar Lonial, Joan Bladé, María‐Victoria Mateos, Meletios Α. Dimopoulos, Efstathios Kastritis, Mario Boccadoro, Robert Z. Orlowski, Hartmut Goldschmidt, Andrew Spencer, Jian Hou, Wee Joo Chng, Saad Z. Usmani, Elena Zamagni, Kazuyuki Shimizu, Sundar Jagannath, Hans Erik Johnsen, Evangelos Terpos, Tony Reiman, Robert A. Kyle, Pieter Sonneveld, Paul G. Richardson, Philip L. McCarthy, Heinz Ludwig, Wen-Ming Chen, Michèle Cavo, Jean‐Luc Harousseau, Suzanne Lentzsch, Jens Hillengaß, Antonio Palumbo, Alberto Órfão, S. Vincent Rajkumar, Jesús F. San Miguel, Hervé Avet‐Loiseau
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial
Peter M. Voorhees, Jonathan L. Kaufman, Jacob P. Laubach, Douglas W. Sborov, Brandi Reeves, Cesar Rodriguez, Ajai Chari, Rebecca Silbermann, Luciano J. Costa, Larry D. Anderson, Nitya Nathwani, Nina Shah, Yvonne A. Efebera, Sarah A. Holstein, Caitlin Costello, Andrzej Jakubowiak, Tanya M. Wildes, Robert Z. Orlowski, Kenneth H. Shain, Andrew J. Cowan, Séan Murphy, Yana Lutska, Huiling Pei, Jon Ukropec, Jessica Vermeulen, Carla de Boer, Daniela Hoehn, Thomas S. Lin, Paul G. Richardson
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
Paul G. Richardson, Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje, Eva Medvedova, Philip L. McCarthy, Edward N. Libby, Peter M. Voorhees, Robert Z. Orlowski, Larry D. Anderson, Jeffrey A. Zonder, Carter P. Milner, Cristina Gasparetto, Mounzer Agha, Abdullah Khan, David D. Hurd, Krisstina Gowin, Rammurti T. Kamble, Sundar Jagannath, Nitya Nathwani, Melissa Alsina, Robert F. Cornell, Hamza Hashmi, Erica Campagnaro, Astrid C. Andreescu, Teresa Gentile, Michaela Liedtke, Kelly Godby, Adam D. Cohen, Thomas H. Openshaw, Marcelo C. Pasquini, Sergio Giralt, Jonathan L. Kaufman, Andrew J. Yee, Emma C. Scott, Pallawi Torka, Amy Foley, Mariateresa Fulciniti, Kyle Hebert, Mehmet Samur, Kelly Masone, Michelle E. Maglio, Andrea A. Zeytoonjian, Omar Nadeem, Robert Schlossman, Jacob P. Laubach, Claudia E. Paba‐Prada, Irene M. Ghobrial, Aurore Perrot, Philippe Moreau, Hervé Avet‐Loiseau, Michel Attal, Kenneth C. Anderson, Nikhil C. Munshi
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial
Shaji Kumar, Susanna Jacobus, Adam D. Cohen, Matthias Weiss, Natalie S. Callander, Avina K. Singh, Terri L. Parker, Alexander Menter, Xuezhong Yang, Benjamin M. Parsons, Pankaj Kumar, Prashant Kapoor, Aaron S. Rosenberg, Jeffrey A. Zonder, Edward A. Faber, Sagar Lonial, Kenneth C. Anderson, Paul G. Richardson, Robert Z. Orlowski, Lynne I. Wagner, S. Vincent Rajkumar
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma
Nina Shah, Li Li, Jessica M McCarty, Indreshpal Kaur, Eric Yvon, Hila Shaim, Muharrem Müftüoğlu, Enli Liu, Robert Z. Orlowski, Laurence J.N. Cooper, Dean A. Lee, Simrit Parmar, Kai Cao, Catherine Sobieiski, Rima M. Saliba, Chitra Hosing, Sairah Ahmed, Yago Nieto, Qaiser Bashir, Krina K. Patel, Catherine M. Bollard, Muzaffar H. Qazilbash, Richard E. Champlin, Katy Rezvani, Elizabeth J. Shpall